Aigner A, Muss N, Krempler F, Fenninger H, Sandhofer F
Dtsch Med Wochenschr. 1983 Feb 25;108(8):293-8. doi: 10.1055/s-2008-1069543.
The influence of acute beta 1-receptor blockade using 50 mg metoprolol or beta 1/beta 2-blockade using 40 mg propranolol resulted in an equipotent reduction of cardiac frequency and systolic blood pressure without influencing diastolic pressure in ten healthy probands. There was no reduction of maximal bicycle ergometric exercise by either beta-receptor blocking agent. Serum glucose levels did not change during metoprolol in comparison to pre-test values. In contrast, propranolol resulted in a significant decrease of glucose levels during maximal exercise and 5 minutes after end of exercise. Plasma lactate was moderately lowered by both beta-receptor blockers after 20 min constant exercising when compared to pre-medication. Both substances reduced the insulin level in a comparable way during the exercise test. Serum triglyceride concentrations did not alter significantly during exercise tests. Serum free fatty acid levels showed a decreasing tendency until maximal exercise; however, there was no significant difference between values obtained with metoprolol or propranolol and drug-free pre-test.
在10名健康受试者中,使用50毫克美托洛尔进行急性β1受体阻滞或使用40毫克普萘洛尔进行β1/β2受体阻滞,均可使心率和收缩压等量降低,而不影响舒张压。两种β受体阻滞剂均未降低最大自行车测力计运动能力。与测试前值相比,美托洛尔治疗期间血清葡萄糖水平未发生变化。相比之下,普萘洛尔导致最大运动期间及运动结束后5分钟血糖水平显著降低。与用药前相比,在持续运动20分钟后,两种β受体阻滞剂均使血浆乳酸适度降低。在运动试验期间,两种药物以相似的方式降低胰岛素水平。运动试验期间血清甘油三酯浓度无显著变化。血清游离脂肪酸水平在最大运动前呈下降趋势;然而,美托洛尔或普萘洛尔组与无药测试前的值之间无显著差异。